US 10711312
Methods for immunotherapy-based treatment and assessment of cancer
granted A61KA61K2039/505A61K2039/55
Quick answer
US patent 10711312 (Methods for immunotherapy-based treatment and assessment of cancer) held by The Regents of the University of California expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/55